cGxP.wire https://validator.w3.org/feed/docs/rss2.html Phanes Therapeutics Gains FDA Fast Track for Spevatamig HCW Biologics Advances HCW9302 in Alopecia Areata Acurx Pharmaceuticals Advances Ibezapolstat Toward Phase 3 PMV Pharmaceuticals Completes PYNNACLE Ovarian Cancer Enrollment Capricor Advances Deramiocel as FDA Review Continues Moleculin Biotech Advances MIRACLE Trial in Relapsed AML Daré Bioscience Advances Women’s Health Commercial Strategy Photocure Advances FDA Reclassification of Blue Light Cystoscopy Helus Pharma Completes Phase 3 HLP003 Enrollment in MDD Aidoc Secures Medicare Payment for AI Body CT Triage Lantern Pharma Advances AI-Driven Drug Discovery Strategy Evaxion AI Platform Drives Next-Gen Vaccine Development Perimeter Advances AI Breast Cancer Surgery With Claire Medicenna Advances MDNA11 and Bizaxofusp Clinical Programs Annovis Advances Buntanetap in Alzheimer’s Phase 3 IceCure Highlights Cryoablation Advances in Breast Cancer Care Quantum BioPharma Advances Lucid-MS Into Phase 2 Lupus Foundation Awards Grants to Advance Targeted Research Akari Therapeutics and Whitehawk Expand Dual-Payload ADC Strategy ArkBio Advances Ziresovir in FDA-Approved Phase II RSV Trial Fate Therapeutics Advances FT819 in Lupus Nephritis FDA Authorizes Simparica TRIO for Screwworm in Dogs SK bioscience Advances RSV Antibody Clinical Development Outlook Therapeutics Targets U.S. Launch of FDA-Approved LYTENAVA Genedata Advances AI Biomarker Discovery in Alzheimer’s Research Leap Therapeutics Reports DKK1 Findings in CRC Study Results Function and NYU Partner on Early Disease Detection Research Vesalio Advances pVasc NET with FDA 510(k) Clearance Rigel Launches VEPPANU for ESR1-Mutated Breast Cancer Atrium Therapeutics Earns $15M BMS Milestone Payment Neuralytix Expands iD3 System for Spine Surgery Mendaera Reports 98% Success for Focalist System Zoetis Receives FDA EUA for Simparica Trio in Dogs Pfizer and Valneva Secure EMA Validation for Lyme Vaccine Freenome Gains FDA Breakthrough Device Designation Bristol Myers Squibb Wins FDA Approval for ZENBEXUS Taiho Oncology Advances Zipalertinib in Phase 3 Trial Eupraxia Reports Durable EoE Symptom Improvements With EP-104GI Tvardi Therapeutics Highlights TTI-109 Potential in Ulcerative Colitis Photys Therapeutics and Polymed Begin Phase 1 Trial of PHT-776 Summit Therapeutics Gains China Approval for Ivonescimab Sagimet Biosciences Secures FDA Clearance for Acne Phase 3 Trial Biomea Fusion Doses First Patient in Obesity OPAL Study ArkBio Advances AK0406 with China IND Approval Pharming Launches Joenja in Japan for APDS Patients Salus Scientific Advances Radiation Safety with AeroShield Cycle Pharmaceuticals Partners With Forma Life Sciences for CAVHANZA Supply Sumitomo Pharma America Doses First Patient With DSP-3077 Aurisco Pharmaceutical Passes USFDA Inspection for Oligos PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy Program